Cons Of Allergy Shots: Six Honest Downsides
Allergy shots carry six documented cons: a 3–5 year time commitment, approximately 39 in-clinic visits in year one with mandatory 30-minute observations, a 56.1% dropout rate before reaching maintenance (Tkacz 2021), a 16% local-reaction rate per injection, a 0.1% systemic-reaction rate, and a minimum $3,120 out-of-pocket cost over three years (Stachler 2020). The therapy works biologically when completed — but most US starters do not complete the course.
16 peer-reviewed sources
Six cons of allergy shots: multi-year time commitment, high in-office visit burden, documented 56.1% dropout before maintenance, 16% local reaction rate, 0.1% systemic reaction risk, and minimum $3,120 three-year out-of-pocket cost.
Key facts
In a 2026 real-world study of 2,897 patients, sublingual immunotherapy delivered through telemedicine reported adherence above 90% — relevant here because dropping out is the most common practical failure of any immunotherapy course.
Honest downsides every prospective patient should weigh
Allergy shots are effective when completed — the Cochrane meta-analysis of 51 trials confirms symptom reduction, and the Durham 1999 NEJM study confirms durable post-treatment remission. But six structural cons determine whether a specific patient can actually access that benefit. These cons are real and quantified; they are not exaggerated. Characterizing them accurately is what enables a legitimate candidacy decision.
Before committing to a 3–5 year SCIT course, Curex at-home IgE testing with allergist review confirms the dominant sensitization — necessary because committing to the cons (time, visit burden, observation, local and systemic reaction risk) only makes sense when the immunotherapy plan correctly targets the allergen driving symptoms.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Want fewer visits without skipping safety? Check your eligibility
Curex's at-home SCIT keeps allergist oversight and an epinephrine safeguard while cutting the weekly clinic trips described above.
See if you qualifyCurex allergy shot serum is compounded at a specialty pharmacy for each patient, and the FDA does not review compounded products for safety or efficacy.
Frequently asked questions
Are allergy shots a scam?
No. Allergy shots (SCIT) are a legitimate, decades-old medical treatment with real clinical trial evidence behind it, including a Cochrane review showing a meaningful symptom-reduction effect. What sometimes feels scam-like is the cost and visit burden — thousands of dollars out of pocket and dozens of in-office visits over several years — which is real and documented, not evidence that the treatment itself is fraudulent. The honest takeaway is that shots work for many patients but come with genuine downsides worth weighing before committing.
What are the biggest cons of allergy shots?
The dominant cons are the visit burden (approximately 39 in-office visits in year one with mandatory 30-minute observation after each injection) and the documented dropout rate — only 43.9% of US starters reach maintenance and 23.9% never returned after their first injection per Tkacz et al. (Curr Med Res Opin 2021, n=103,207). Time commitment (3–5 years), local reactions (~16% per injection), systemic reaction risk (0.1% per visit), and cost ($3,120+ minimum OOP) are the other major cons.
How common are side effects from allergy shots?
Local injection-site reactions occur in approximately 16.3% of individual injections and affect about 78.3% of patients over the course of treatment (Calabria et al., JACI 2009, LOCAL study, n=9,678 injections). Systemic allergic reactions occur in approximately 0.1% of injection visits — most are mild (74% grade 1, urticaria and flushing). Grade 3 anaphylaxis represents about 3% of systemic reactions. Historical fatality rate is approximately 1 per 2.5 million injections.
Are there long-term side effects from allergy shots?
The well-documented side effects are short-term — local injection-site reactions and the rare systemic reaction described above, both tied to the injection itself rather than developing later. There is no strong evidence of serious delayed or cumulative long-term side effects from completing a standard 3-5 year SCIT course; the goal of finishing the full course is durable, long-term symptom relief. If you notice new or unusual symptoms during treatment, report them to your allergist rather than assuming they're unrelated.
Why do so many people quit allergy shots?
Real-world US data from 103,207 patients (Tkacz JP et al., Curr Med Res Opin 2021) found 56.1% of starters do not reach maintenance and 23.9% never returned after the first injection. The primary driver is the in-office visit burden — approximately 39 visits in year one, each requiring a 30-minute observation period. Work schedule conflicts, distance to clinic, and the slow timeline of noticeable benefit during the build-up phase are the most commonly cited adherence barriers.
Are allergy shots dangerous?
The systemic reaction risk is real but uncommon and has been stable across over 23 million injection visits in national surveillance (Epstein TG et al., JACIP 2014). At 0.1% per injection visit, systemic reactions — mostly mild urticaria or flushing — occur in about 1.9% of patients over a treatment course. Grade 3 anaphylaxis is about 0.003% of visits. Historical fatality rate is approximately 1 per 2.5 million injections, with one confirmed fatality documented across 23.3 million injection visits from 2008 to 2012.
How much do allergy shots cost out of pocket?
Stachler (AAOA, December 2020) estimated a minimum of $3,120 out of pocket over three years at $20 per injection visit ($20 × 52 weeks × 3 years), rising to $6,240 for patients requiring two serums. At hospital outpatient departments (HOPDs), costs are substantially higher: PBS NewsHour documented a 2024 case with $24,400 total billed (M Health Fairview MN), and KFF/NPR documented a 2018 Stanford case with $48,329 billed. Site of care is the largest cost variable.
Can you give yourself allergy shots at home to avoid the visit burden?
Increasingly, yes, for eligible patients. Traditionally, subcutaneous immunotherapy was given only in-clinic because systemic reactions require immediate epinephrine access. Curex makes at-home self-administration available for eligible patients with a specific safeguard stack: a serum sterile-compounded to USP <797> standards, a prescribed epinephrine auto-injector confirmed on hand before the first dose, the first injection from each new vial supervised live by trained Curex clinical staff, gradual week-by-week dose escalation, and board-certified allergist oversight — with pricing confirmed in a current program quote. A large safety study of self-administered allergen immunotherapy (Schaffer et al., 2015) found a systemic reaction rate of just 0.16% per patient across 23,614 patients, with no fatalities.
What are my options if standard in-office allergy shots don't fit my schedule?
If the visit burden described above doesn't fit your life, your main alternatives are at-home self-administered SCIT through a telehealth program like Curex, which keeps the safety features (epinephrine on hand, supervised first injections, allergist oversight) while removing weekly clinic trips, or sublingual tablets regulated by the FDA, or off-label sublingual drops taken at home. Each option trades off differently on evidence strength, cost, and convenience, so discuss which fits your allergens and schedule with a board-certified allergist.
Are allergy shots worth it despite the cons?
For the right patient — confirmed IgE sensitization, the capacity to sustain 3–5 years of treatment, and an allergen with strong RCT evidence — the documented benefits (Cochrane SMD −0.73, durable post-treatment remission, pediatric asthma prevention) outweigh the cons. For patients who cannot sustain the visit commitment, joining the 56.1% who do not complete the course means incurring most of the cons without capturing the full benefit. An honest candidacy assessment is the prerequisite to any worth-it conclusion.
What contraindications make allergy shots a bad choice?
Per AAAAI/ACAAI practice parameters (Cox 2011), allergy shots are contraindicated or require extreme caution in patients with poorly controlled asthma (FEV1 below 70% predicted), ACE inhibitor use, unstable cardiovascular disease, untreated active malignancy, severe immunodeficiency, and at the initiation of pregnancy. Beta-blocker use is not an automatic contraindication — it requires individualized provider review and enhanced informed consent, but is not an automatic exclusion.
How long does it take to see results with Curex's at-home allergy shots?
There's no single universal timeline — allergy shots work through gradual immune retraining, and most protocols run 3 to 5 years total, with meaningful, durable symptom relief typically building over that course rather than appearing immediately. Some patients notice partial improvement during the later build-up and maintenance phases, but the slow pace of early benefit is itself one reason some patients discontinue, as noted above. Your allergist can give you a more personalized expectation based on your allergens and starting severity.
Related Articles
Purpose of Allergy Shots: Mechanism & Clinical Intent
Allergy shots induce immune tolerance — IgE to IgG4. Three intents: symptom relief (Cochrane SMD −0.73), less medication, and durable disease modification.
Read moreAllergy Shots for Pollen: Who Qualifies | Curex Guide
Yes, allergy shots target pollen via SCIT. Cox 2011 candidacy threshold, FDA SLIT tablets, per-allergen efficacy, and Curex at-home shots — all covered.
Read moreAllergy Shots Effectiveness – RCT Evidence | Curex
Allergy shots effectiveness: Cochrane SMD −0.73 (51 RCTs, 2,871 patients). Per allergen: venom 95%+, grass 80%, cat 62%, Alternaria 63.5%. Real-world ceiling: 43.9% reach maintenance.
Read moreCat Allergy Vaccine Explained | Curex SCIT Guide
Cat allergy vaccine means three different things. SCIT uses FDA-standardized Fel d 1 extract for ~72% symptom relief. No one-shot cure exists.
Read moreSuccess Rate of Allergy Shots – Per Allergen | Curex
Success rate of allergy shots by allergen: venom >95%, grass ~80% medication reduction, cat ~62%, Alternaria 63.5% (yr 3). No single uniform percentage exists — here's the data.
Read moreDo Allergy Shots Work? Evidence & Honest Verdict | Curex
Do allergy shots work? Meta-analyses of 51 RCTs show 33-85% symptom reduction — but 20-50% of patients are low responders. Here's the honest evidence.
Read moreGet your allergy shots — without the clinic.
Curex at-home shots require a program quote. Confirm what is included in your plan — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
Program quote required · Remaining payments for shipped treatment are collected on cancellation
Curex allergy shot serum is compounded at a specialty pharmacy for each patient, and the FDA does not review compounded products for safety or efficacy.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.